When: Q3'26 print with revenue ≥+8% YoY and FCF ≥$1.4B with raised FY guide

Then: Re-evaluate thesis; fundamental trigger may or may not confirm momentum

HOLD - preserve optionality without adding risk; existing holders maintain exposure but do not add new capital until confirmation signals emerge

• UNP fell 12% from 314 to 276 in roughly six weeks and has not resolved the correction; stock sits below 10 EMA, below 20-period Bollinger midline, and almost 13 points below 50 SMA at 288.84
• Premium multiples at 22.4x trailing earnings versus 5-year rail average of 18-20x are only defensible when volume momentum is strong and macro is cooperating - neither condition is currently met
• Q2'26 FCF surge of 2.2B was off a depressed Q2'25 base; normalized quarterly FCF is likely 1.4-1.7B implying 23-27x FCF multiple on 164B market cap, rich for capital-intensive cyclical
• Working capital improvement of 700-800M is a timing artifact, not compounding operational efficiency - reversal expected in H2'26
• 6% recession odds is consensus base case, not bullish; risk is 6% becoming 12%, which can happen in weeks not quarters
• 10-year yields at 2002 highs not dismissed by market digestion; intermodal at roughly 40% of mix is rate-sensitive without recovery confirmed
• Merger approval is already implicit in current 22x earnings valuation; STB hostility creates significant block/restructure risk with asymmetric downside
• MACD cross below zero is textbook bear-market rally pattern; 50 SMA rolling over at 1 point every 2 days indicates medium-term trend rollover
• 25-33% starter position with 1.5 ATR stop (7.23 points on 276 entry) risks 2.5-5% of capital for thesis predicated on multiple unconfirmed catalysts
• Full downside scenario targets 200 SMA at 263, representing another 5% of pain beyond already-stressed tape

→ vs aggressive: Rising 200 SMA at 263.12 and best-in-class margins describe a structural floor but not an attractive entry point - conflating trend integrity with new capital deployment opportunity

→ vs aggressive: Q2'26 2.2B FCF surge off depressed Q2'25 base means normalized FCF is 1.4-1.7B quarterly (6-7B annualized), implying 23-27x FCF multiple on 164B market cap - not the compelling value claimed

→ vs aggressive: 6% recession odds is the consensus base case, not a bullish signal; actual risk is 6% becoming 12%, which can occur in weeks and compress industrial multiples sharply

→ vs aggressive: Merger optionality is already priced into 22x earnings - current valuation assumes approval probability, so the catalyst is not free; block or restructure creates asymmetric downside without offset

→ vs aggressive: MACD cross below zero followed by histogram improvement is the hallmark of bear-market rallies, not early accumulation - one positive bar does not reverse multi-month trend

→ vs aggressive: Working capital release of 700-800M is mechanical accounts payable/receivable normalization, not compounding efficiency - will reverse mechanically in H2'26

→ vs aggressive: 25-33% starter with 1.5 ATR stop (7.23 points) risks 2.5-5% of capital for position predicated on unconfirmed catalysts in elevated tail risk environment - not disciplined risk management

HOLD with conditional scaling triggers - existing holders maintain exposure but do not commit new capital until confirmation signals fire; if/when confirmed, add 10-15% starter position with defined stop losses

• 200 SMA at 263.12 is structural support (destination) but NOT an entry signal - structural support ≠ high-probability entry
• 50 SMA at 288.84 is rolling over at roughly 1 point every two days - higher-probability interpretation is relief rally within larger downtrend until price reclaims it
• Technical probability is ~55/45 in favor of bear-market-rally interpretation with significant variance - not high enough to commit new capital aggressively but not high enough to abandon position
• Working capital normalized to -$79M from -$2.27B over four quarters - ~30-50% of benefit is likely non-recurring
• Normalized quarterly FCF estimated at $1.7-1.9B using blended Q2'25/Q2'26 approach ($1.8B midpoint), not $2.2B aggressive or $1.4-1.5B conservative
• Annualized normalized FCF of ~$7.2B implies ~22-23x normalized FCF multiple, more demanding than 19.5x forward P/E suggests
• Q2'26 OCF of $3.076B annualizes to ~$12.3B, or 7.5% OCF yield against $164B market cap; if half working capital reverses, FCF yield drops to 3.7-4.3%
• Merger optionality is partially priced in at ~$30-50/share - UNP trades at 22.4x P/E vs. 17-18x without merger probability
• STB approval is NOT a foregone conclusion - UNP-NS would create transcontinental east-west monopoly with concentration concerns beyond modern-era precedent
• Aggressive analyst overstates FCF by using best quarter as run rate; conservative analyst understates by using trough quarter; truth is blend
• Quality premium justified: 40.98% operating margin and 39.7% ROE put UNP in top decile globally - not comparable to 5-year sector average
• 6% recession odds is genuinely low; treating tail risk as one-way bet is overweighting downside
• Wait-and-see cost is only $1.50-2.00 spread from 276 to confirmation trigger at 277.95/278.50 - cheap option worth paying for confirmation
• Q3 earnings (~3 weeks out) are critical binary: needs YoY revenue growth ≥8% and FCF ≥$1.4B to confirm inflection sustains
• Single-name position with 0.95 beta and 40% intermodal exposure warrants disciplined sizing, not all-or-nothing calls
• Confirmation signal #1: 278.50 close above with volume; #2: STB merger approval; #3: Q3 earnings thresholds met; #4: 10Y yields break below 4.5%
• Scale up new adds only if signal persists for 2-3 sessions AND 50 SMA stops rolling over

→ vs aggressive: Uses 'structural support exists' (200 SMA at 263.12) as reason to buy - this is a category error; structural support is a destination, not an entry signal; same logic applied August 2025 at 295 would have been correct eventually but cost 12% drawdown first

→ vs aggressive: FCF math is technically correct but framing is slippery; annualizing Q2'26 OCF of $3.076B yields 7.5% OCF yield but if half working capital benefit reverses, FCF yield drops to 3.7-4.3% against $164B market cap; using best quarter as run rate overstates underlying earning power

→ vs aggressive: Treats merger approval as 'free option' worth 'hundreds of dollars per share' - merger optionality is already partially priced in at ~$30-50/share; STB approval is NOT a foregone conclusion given transcontinental monopoly concerns and increasingly skeptical STB stance

→ vs conservative: Compares 22.4x trailing P/E to 5-year sector average of 18-20x is misleading; UNP's 40.98% operating margin and 39.7% ROE put it in top decile of global industrials, not comparable to average railroad; quality premium of 15-20% is earned

→ vs conservative: Says working capital is 'by definition a timing artifact' - too neat; working capital improvement from -$2.27B to -$79M reflects real operational changes; claiming ALL reverses is same overreach as aggressive analyst using best quarter; 30-50% non-recurring is more accurate

→ vs conservative: Treats tail risk as one-way bet; 6% recession odds can move to 12% in weeks but same logic says it can move to 3% - base case really is soft landing and 6% is genuinely low; overweighting tail risk relative to base case probability

→ vs conservative: Contradicts own argument by acknowledging existing holders 'maintain upside' while arguing wait-and-see - cost of waiting for confirmation is only $1.50-2.00 spread (from 276 to 277.95/278.50), which is cheap for 1.56 R/R setup; underestimates how low-cost the option actually is